CABRAL, F.V.PELEGRINO, M.T.SEABRA, A.B.RIBEIRO, M.S.2019-10-022019-10-02CABRAL, F.V.; PELEGRINO, M.T.; SEABRA, A.B.; RIBEIRO, M.S. Could NO-releasing chitosan nanoparticles improve photodynamic therapy on cutaneous leishmaniasis?. In: LATIN AMERICA OPTICS AND PHOTONICS CONFERENCE, November 12-15, 2018, Lima, Peru. <b>Resumo expandido...</b> Washington, DC, USA: OSA, 2018. DisponÃvel em: http://repositorio.ipen.br/handle/123456789/30161.http://repositorio.ipen.br/handle/123456789/30161Photodynamic inactivation (PDI) and NO-releasing chitosan nanoparticles (CSNPs) were associated to treat cutaneous leishmaniasis in mice to verify synergism between therapies. Parasite burden, lesion size and hyperalgesia were analyzed. CSNPs were not able to improve PDI.openAccessCould NO-releasing chitosan nanoparticles improve photodynamic therapy on cutaneous leishmaniasis?Resumo de eventos cientÃficos0000-0002-4203-1134https://orcid.org/0000-0002-4203-1134